AIDS Group Files Second Suit Seeking Retroactive 340B Discounts
OPA Budget Remains Stuck at 2010 Level Through March 4
Calif. Counties and Supporters File Briefs in Major U.S. Supreme Court 340B Case
HRSA to Notify Manufacturers and Children's Hospitals About Orphan Drug Fix
Health Reform's 340B Provisions Unaffected by Ruling in Virginia Lawsuit
Congress Passes Orphan Drug Fix for Children's Hospitals
Senate to Vote to Lift Orphan Drug Ban for Children's Hospitals
Access our Quarterly Print Newsletter!
AIDS Group Sues BMS for Retroactive 340B Discounts
Federal Deficit Reduction Panel Recommends Expanding Rebates to Medicare Part D
December 23, 2010—President Obama signed a temporary spending bill for the federal government yesterday that continues funding for the Office of Pharmacy Affairs (OPA) at its fiscal 2010 level of $2.2 million through early March.
OPA has warned that it will not implement a new 340B dispute resolution process or another to impose civil monetary penalties on drug manufacturers that knowingly overcharge 340B providers if it does not get additional funding.
OPA began the rulemaking process for those two provisions because Congress gave it deadlines to do so in health care reform. If no additional money to implement reform is coming from Congress, it is unclear when or even if the office will begin drafting other 340B-related rules pursuant to the Affordable Care Act.
Also, Congress ended its 111th session yesterday without acting on proposed legislation that would have authorized a limited expansion of the 340B drug discount program to the inpatient setting.
